Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia

Press/Media: Press / Media

PeriodSep 16 2019 → Sep 17 2019

Media coverage

12

Media coverage

  • TitleAmplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletPipelineReview
    CountrySpain
    Date9/17/19
    PersonsGEORGE THOMPSONIII
  • TitleAmplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletPR Newswire
    CountryUnited States
    Date9/16/19
    PersonsGEORGE THOMPSONIII
  • TitleAmplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletPR Newswire
    CountryUnited States
    Date9/16/19
    PersonsGEORGE THOMPSONIII
  • TitleAmplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletPR Newswire
    CountryUnited States
    Date9/16/19
    PersonsGEORGE THOMPSONIII
  • TitleAmplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletIndia Pharma News
    CountryIndia
    Date9/16/19
    PersonsGEORGE THOMPSONIII
  • TitleAmplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletBioSpace
    CountryUnited States
    Date9/16/19
    PersonsGEORGE THOMPSONIII
  • TitleAmplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletManchester Times
    CountryUnited States
    Date9/16/19
    PersonsGEORGE THOMPSONIII
  • TitleAmplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletTullahoma News
    CountryUnited States
    Date9/16/19
    PersonsGEORGE THOMPSONIII
  • TitleAmplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletHerald Chronicle
    CountryUnited States
    Date9/16/19
    PersonsGEORGE THOMPSONIII
  • TitleAmplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletElk Valley Times
    CountryUnited States
    Date9/16/19
    PersonsGEORGE THOMPSONIII
  • TitleAmplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletErie News Now
    CountryUnited States
    Date9/16/19
    PersonsGEORGE THOMPSONIII
  • TitleAmplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletABC6.com
    CountryUnited States
    Date9/16/19
    PersonsGEORGE THOMPSONIII